Literature DB >> 8021447

The sleeping giant. Antimicrobial resistance.

J M Casellas1, M G Blanco, M E Pinto.   

Abstract

Resistance to most of the antimicrobial agents in use today is present in Latin America as of this publication. Their underlying mechanisms are in place and an even more serious situation is foreseen in the years to come. Both nosocomial and common community-acquired infections have changed to require more complex ways of management. Although newer antibiotics take the place of the older ones, wiser and more restrictive usage of the currently available antibiotics is needed. This may be obtained through education and with the amplification of national and supranational networks of surveillance, which could anticipate trends in resistance.

Mesh:

Year:  1994        PMID: 8021447

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  4 in total

1.  Confronting antibiotic-resistant organisms - A Canadian perspective.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1995-05

2.  Antimicrobial resistance - Judicious use is the key.

Authors:  John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

Review 3.  Controlling antibiotic resistance by quelling the epidemic of overuse and misuse of antibiotics.

Authors:  J Conly
Journal:  Can Fam Physician       Date:  1998-09       Impact factor: 3.275

Review 4.  Epidemiology of quinolone resistance: Europe and North and South America.

Authors:  F W Goldstein; J F Acar
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.